Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Raphael Bueno, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
completed student projects
From OR to bench: Identification of variables affecting success in generating patient derived organotypic spheroids (PDOTS)
Soma Weiss, 09/01/17 - 03/30/19

Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
Most Recent  |  List All
  1. R01EB025964 (JAGADEESAN, JAYENDER) Sep 15, 2018 - May 31, 2022
    NIH
    Lung Navigation System for Localizing and Resecting Nodules
    Role: Co-Principal Investigator
  2. R01CA120528 (BUENO, RAPHAEL) Apr 7, 2006 - Jul 31, 2022
    NIH
    Prospective Validation of Prognostic and Predictive Molecular tests in Mesothelioma
    Role: Principal Investigator
  3. R33CA100315 (BUENO, RAPHAEL) Aug 1, 2004 - Jul 31, 2008
    NIH
    Gene Ratio Based Prognosis in Mesothelioma
    Role: Principal Investigator
  4. R21CA100315 (BUENO, RAPHAEL) Aug 1, 2004 - Jul 31, 2005
    NIH
    Gene Ratio Based Prognosis in Mesothelioma
    Role: Principal Investigator
  5. R21CA098501 (BUENO, RAPHAEL) Jul 1, 2003 - Jun 30, 2006
    NIH
    Gene Ratios for Lung Cancer Detection and Prognosis
    Role: Principal Investigator

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Paajanen J, Jaklitsch MT, Bueno R. Contemporary issues in the surgical management of pleural mesothelioma. J Surg Oncol. 2023 Feb; 127(2):343-354. PMID: 36630097; PMCID: PMC9839311.
    Citations:    Fields:    Translation:Humans
  2. Kim S, Kim S, Wang SX, Kanwar R, Bryan DS, Bueno R, Marshall MB. Gender differences in medicare payments to cardiothoracic surgeons in 2019. Eur J Cardiothorac Surg. 2022 Dec 20. PMID: 36538926.
    Citations:    Fields:    
  3. Dolan DP, Polhemus E, Lee DN, Mazzola E, Jaklitsch MT, Wee JO, Bueno R, Swanson SJ, White A. Hyperthermic intraoperative chemotherapy (HIOC) for Stage IVa thymic malignancy may improve 5-year disease-free survival. J Surg Oncol. 2022 Dec 01. PMID: 36453475.
    Citations:    Fields:    
  4. Paajanen J, Bueno R, De Rienzo A. The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma. Int J Mol Sci. 2022 Nov 03; 23(21). PMID: 36362209; PMCID: PMC9658134.
    Citations:    Fields:    Translation:Humans
  5. Weiss KD, Deeb AL, Wee JO, Swanson SJ, Bueno R, Jaklitsch MT, Rochefort MM. When a segmentectomy is not a segmentectomy: Quality assurance audit and evaluation of required elements for an anatomic segmentectomy. J Thorac Cardiovasc Surg. 2022 Sep 14. PMID: 36244821.
    Citations:    Fields:    
  6. Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, Ozgenc I, Noureddine M, Meisenheimer B, Chen M, Piel B, Spicer N, Obua B, Messier CM, Shannon E, Mahadevan NR, Tani T, Schol PJ, Lee-Hassett AM, Zlota A, Vo HV, Ha M, Bertram AA, Han S, Thai TC, Gustafson CE, Venugopal K, Haggerty TJ, Albertson TP, Hartley AV, Eser PO, Li ZH, Cañadas I, Vivero M, De Rienzo A, Richards WG, Abu-Yousif AO, Appleman VA, Gregory RC, Parent A, Lineberry N, Smith EL, Jänne PA, Miret JJ, Tolstorukov MY, Romee R, Paweletz CP, Bueno R, Barbie DA. Activation of Tumor-Cell STING Primes NK-Cell Therapy. Cancer Immunol Res. 2022 08 03; 10(8):947-961. PMID: 35678717; PMCID: PMC9357206.
    Citations: 1     Fields: